Home › Funds › WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC › KRYS

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC position in KRYS

KRYSTAL BIOTECH INC · Health Care

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reported holding 520,925 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$173.2M, representing 0.56% of its reported portfolio and ranking #39 among its reported holdings. WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed KRYS holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)520.92K sh
Reported value held$173.24M
Portfolio Weight0.56%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's KRYS position evolved

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC first disclosed a stake in KRYS in Q2 2025 at 91,099 shares (US$12.5M). The position peaked in Q2 2026 at 570,153 shares, worth US$211.9M. Across 6 filings, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 520,925 shares valued at US$173.2M — a reduction of -49,228 shares quarter over quarter.. Notable position changes include a 64% increase in Q3 2025 (shares rose 40% over the following quarter), a 152% increase in Q4 2025 (shares rose 5% over the following quarter), a 40% increase in Q2 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 91.10K $12.52M New
Q3 2025 149.30K $26.36M Add
Q4 2025 376.34K $92.78M Add
Q1 2026 407.18K $105.18M Add
Q2 2026 570.15K $211.91M Add
Q3 2026 520.92K $173.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 41 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC held KRYS?

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed KRYS holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's current position in KRYS?

As of Q3 2026, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds 520.92K shares of KRYS (KRYSTAL BIOTECH INC), valued at $173.24M, representing 0.56% of its reported portfolio and ranking #39.

Has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC been buying or selling KRYS?

In the latest 13F filing (Q3 2026), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reduced its position in KRYS. The position peaked in Q2 2026 at 570.15K shares.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.